These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 147084)

  • 1. Effect of some mucopolysaccharides on activated factor X.
    Palazzini E; Procida C
    Biochem Pharmacol; 1978 Feb; 27(4):608-10. PubMed ID: 147084
    [No Abstract]   [Full Text] [Related]  

  • 2. The potency of heparin-like activity of glycosaminoglycans released by human endothelial cells in culture.
    Shimada K; Kusumoto I; Ozawa T
    Experientia; 1985 May; 41(5):671-3. PubMed ID: 3996545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of factor Xa from neutralization by the heparin-antithrombin complex.
    Teitel JM; Rosenberg RD
    J Clin Invest; 1983 May; 71(5):1383-91. PubMed ID: 6222069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GAGs-potentiated inhibition of thrombin, factor Xa and plasmin in plasma and in a purified system containing antithrombin III - correlation with total charge density.
    Cofrancesco E; Vigo A; Pogliani EM
    Thromb Haemost; 1981 Dec; 46(4):749-51. PubMed ID: 6460339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulant activity of galactosaminoglucuronoglycan: a pharmacological study.
    Matera M; Scalia S
    Drugs Exp Clin Res; 1991; 17(1):65-73. PubMed ID: 1833172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects on platelets and on the clotting system of four glycosaminoglycans extracted from hog mucosa and one extracted from aortic intima of the calf.
    Cella G; Scattolo N; Luzzatto G; Stevanato F; Vio C; Girolami A
    J Med; 1986; 17(5-6):331-46. PubMed ID: 2953835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sulfated mucopolysaccharides and of endogenous plasma heparin (s) on thromboplastin generation.
    ENGELBERG H
    Proc Soc Exp Biol Med; 1962 Apr; 109():814-7. PubMed ID: 13890231
    [No Abstract]   [Full Text] [Related]  

  • 8. Heparin-accelerated inhibition of activated factor X by its natural plasma inhibitor.
    Yin ET; Wessler S
    Biochim Biophys Acta; 1970 Feb; 201(2):387-90. PubMed ID: 5418732
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of activated factor X-induced platelet aggregation: the role of heparin and the plasma inhibitor to activated factor X.
    Yin ET; Giudice LC; Wessler S
    J Lab Clin Med; 1973 Sep; 82(3):390-8. PubMed ID: 4728289
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of heparin and other acid mucopolysaccharides on the activity of a cytolytic pore-forming protein (perforin) from cytotoxic T-lymphocytes.
    Ishiura S; Koizumi H; Tsukahara T; Sugita H
    J Biochem; 1988 Jan; 103(1):11-3. PubMed ID: 2966147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The meaning of mucopolysaccharides in immune processes].
    Voss H
    Zentralbl Bakteriol Orig; 1965 Dec; 198(1):211-3. PubMed ID: 4164536
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the effect of mucopolysaccharides and other polyanions on serological reactions].
    Gillert KE
    Zentralbl Bakteriol Orig; 1965 Dec; 198(1):198-205. PubMed ID: 4164535
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mucopolysaccharides (heparin and heparinoids) in therapy].
    Pasotti C
    Farmaco Prat; 1966 Dec; 21(12):633-68. PubMed ID: 4170201
    [No Abstract]   [Full Text] [Related]  

  • 14. Anticoagulant properties of three mucopolysaccharides used in rheumatology.
    Bauer F; Schulz P; Reber G; Bouvier CA
    Thromb Haemost; 1983 Oct; 50(3):652-5. PubMed ID: 6228031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of sulfated mucopolysaccharides on calcification.
    Harris AF; Cotty VF; Barnett L; Seiman A
    Arch Int Pharmacodyn Ther; 1969 Oct; 181(2):489-98. PubMed ID: 4253933
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dose-response relations of N-formyl-chitosan-polysulfuric acid ester (Ro 1-8307) in regard to the activation of the clearing factor & inhibition of coagulation in comparison with heparin in animal experiments & in man].
    REBER K; STUDER A; TOBLER R; KOLLER F
    Acta Haematol; 1959 Jan; 21(1):31-5. PubMed ID: 13626505
    [No Abstract]   [Full Text] [Related]  

  • 17. [Interaction of aminasin and novocain with acid mucopolysaccharides and mucoproteins].
    Bychkov SM; Khazanova AI
    Vopr Med Khim; 1967; 13(5):491-8. PubMed ID: 4235110
    [No Abstract]   [Full Text] [Related]  

  • 18. Transplantation and cytotoxicity changes induced by acid mucopolysaccharides.
    Lippman M
    Nature; 1968 Jul; 219(5149):33-6. PubMed ID: 4232314
    [No Abstract]   [Full Text] [Related]  

  • 19. Modification of immunogenicity on kidney allografts treated with acid mucopolysaccharides.
    Toledo-Pereyra LH; Simmons RL; Najarian JS
    Surg Forum; 1975; 26():331-2. PubMed ID: 129878
    [No Abstract]   [Full Text] [Related]  

  • 20. The acceleration of the inhibition of platelet prothrombinase complex by heparin.
    Ellis V; Scully MF; Kakkar VV
    Biochem J; 1986 Jan; 233(1):161-5. PubMed ID: 3954724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.